title: Insulin independence after conversion to tacrolimus and sirolimus-based immunosuppression in islet-kidney recipients.
authors.forename: Christian
authors.initials: C
authors.lastname: Toso
authors.forename: Philippe
authors.initials: P
authors.lastname: Morel
authors.forename: Pascal
authors.initials: P
authors.lastname: Bucher
authors.forename: Zoltan
authors.initials: Z
authors.lastname: Mathe
authors.forename: Sandrine
authors.initials: S
authors.lastname: Demuylder-Mischler
authors.forename: Domenico
authors.initials: D
authors.lastname: Bosco
authors.forename: Thierry
authors.initials: T
authors.lastname: Berney
authors.forename: José
authors.initials: J
authors.lastname: Oberholzer
authors.forename: James
authors.initials: J
authors.lastname: Shapiro
authors.forename: José
authors.initials: J
authors.lastname: Oberholzer
authors.forename: Jacques
authors.initials: J
authors.lastname: Philippe
mesh_terms: D000328:Adult; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy / Q000601:surgery*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007328:Insulin / Q000008:administration & dosage*; D016381:Islets of Langerhans Transplantation; D016030:Kidney Transplantation; D020123:Sirolimus / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D007166:Immunosuppressive Agents; D007328:Insulin; D020123:Sirolimus; D016559:Tacrolimus